IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Cidara Therapeutics Inc (CDTX)

CUSIP: 171757206 | UD | 320 institutional holders

Quarters

Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Beneficial Ownership — 13D / 13G

Full history →

5%+ stakes reported outside the quarterly cycle. A 13D is due within five business days of the event below, so these figures lead the holders table until the filer's next 13F catches up to them.

HolderShares% of ClassChangeEvent Datevs 13F
13D/ARA Capital Management, L.P.00.0%Fell below 5%Jan 7, 20267d ahead of 13F (3,365,523 sh) · −3,365,523
13D/ARA Capital Management, L.P.

Institutional Holders — Q1 2026

Vanguard Group Inc0
0.0% of portfolio›$0
StyleTurnoverLocationFiled
Vanguard Group Inc
0$00.0%N/AN/AValley Forge, PA2026-05-14
0
0.0% of class · Jan 7, 2026Fell below 5%
7d ahead of 13F (3,365,523 sh) · −3,365,523